Angiotensin-converting enzyme (ACE) levels and ACE gene polymorphisms have been related with hypertension but with contradictory results between populations. We have investigated the association among the allelic distribution of the insertion-deletion (I/D) polymorphism of the ACE gene, identified by polymerase chain reaction (PCR), serum ACE activity determined by spectrophotometry, and the blood pressure (BP), in a Mediterranean population in the southwest of Europe. A total of 1322 randomised individuals were analysed, and a comparative study was conducted analysing 205 indi-
Introduction
The renin-angiotensin system plays a major role in the homeostasis of blood pressure (BP). One of the enzymes of this system is the angiotensin-converting enzyme (ACE) that converts angiotensin I to angiotensin II. ACE is a peptidyl dipeptidase that releases C-terminal dipeptides from substrates. The genetic control of ACE levels has been suggested by identification of an Alu insertion-deletion (I/D) polymorphism of the ACE gene located in intron 16 of this gene (chromosome q 23). [1] [2] [3] The D allele was reported to be a risk factor for several cardiovascular diseases including myocardial infarction, left ventricular hypertrophy and essential hypertension in some populations under study, [4] [5] [6] [7] but could not later be proven in others. [8] [9] [10] [11] [12] [13] To our knowledge there is no evidence of any genetic study of ACE performed in a Mediterranean population.
In the present work we analyse the I/D polymorphism and the serum ACE activity in a Spanish population comprised of 205 individuals with the highest BP levels (fifth quintyl group), and 196 individuals with the lowest BP levels (first quintyl group).
Materials and methods

Study subjects
A cross-sectional study of the general population of the Province of Albacete, located in the southeast of Spain, with a population of 218 462 inhabitants over 18 years of age according to the 1991 census, and with similar demographic characteristics to the rest of the country was carried out in order to establish the prevalence of different cardiovascular risk factors (CVRF). All persons of more than 18 years of age were included. The sample size was calculated on the basis of a previous survey in which a prevalence of peripheral artery disease of 1.4% was registered. To obtain a confidence interval of 0.9% to 1.9% with respect to the expected prevalence of peripheral artery disease, a total of 2121 participants was required. The final sample included 1322 persons. The random stratified sample was examined in two phases with sample sizes proportional to the sizes of local population, ie, 40% of participants were from the capital (urban area), 23.1% from towns of more than 10 000 inhabitants (small urban areas), and 36.9% from towns and villages of less than 10 000 inhabitants (rural areas). During the first phase of the study, participants in each group were selected at random from 22 population zones, whereas in the second phase, participants were selected by systematic random sampling and then contacted.
Baseline information was collected with the use of previously designed questionnaires.
14 This included personal and family history of cardiovascular diseases and risk factors. After completion of the questionnaires, the patient's weight, height and BP were registered. BP was measured following the recommendations of the British Society of Hypertension in the sitting position after 15 min of rest using a conventional mercury sphygmomanometer. The lower of two measurements taken 5 min apart was selected for the study. Systolic and diastolic BP were defined as being the first and fifth Korotkoff sounds, respectively. Seven observers who were previously trained and passed a certification test with a double-headed stethoscope and a video-test conducted the study; this certification was repeated every 3 months.
We selected for this study a subsample from the previously cross-sectional survey, adjusting by age (decades) and sex, of 205 participants with the highest BP values (fifth quintyl group), and compared with 196 participants with the lowest BP levels (first quintyl group). A significant percent of cases had no clinical criteria of hypertension (Table 1) .
In these two groups we analysed the I/D variants of the ACE gene by polymerase chain reaction (PCR) and the levels of ACE using a spectrophotometric assay.
Experimental procedures
For genotype analysis, genomic DNA was extracted from 300 l of whole peripheral blood using a commercial kit (Mammalian Genomic Kristal Kit of Cambridge Technologies, Cambridge, UK) according to the manufacturer's instructions. Oligonucleotide primers used to amplify the I/D region of the human ACE gene were as described by Lindpainter et al. 15 Primers 5Ј GCCCTGCAGGTGTCTGCAGCATGT-3Ј (sense primer) and 5Ј GGATGGCTCTCCCCGCC TTGTCTC-3Ј (antisense primer) produced 319 and 597-bp amplicons for D and I alleles, respectively. Reactions were carried out in a total volume of 25 l containing 0.5 M primers, 2.0 mM deoxynucleotide triphosphate, 1.3 M Cl 2 Mg, 50 mM KCI, 10 mM tris HCI, pH 8.4, 0.1%, Triton X-100, 0.5 units of Taq polymerase and 100 g of human genomic DNA. The thermocycling procedure was carried out in a Perkin-Elmer 2400 thermocycler (Foster City, CA, USA) which consisted of 35 cycles of denaturation at 94°C for 30 sec, annealing at 56°C for 45 sec, and extensions at 72°C for 2 min, followed by a final extension at 72°C for 7 min. The amplification products (D and I alleles) were analysed using 2% agarose electrophoresis. Because the D allele in heterozygous samples is preferentially amplified 15 , each sample found to have the DD genotype was subjected to a second independent PCR amplification, with a primer pair that recognised an insertion-specific sequence. The primers were 5Ј TGGGACCACAGCGCCCGCCACTAC-3Ј (sense primer) and 5ЈTCGCCAGCCCTCCCATGCCCATAA-3Ј (antisense primer). Amplification was carried out under identical PCR conditions except for an annealing temperature of 70°C. The reaction yields a 335-bp amplicon only in the presence of an I allele and no product in samples homozygous for DD. This procedure correctly identified the 4 to 5% of samples with the DI genotype that are misclassified as DD with the insertion-spanning primers.
The enzymatic activity of serum ACE was measured with a kit from Sigma Diagnostics (St Louis, MI, USA), according to the manufacturer's instructions and using an automatic analyser Hitachi 704 (Hitachi, Japan).
Statistical analysis
The distribution of all variables was examined. Differences between groups were examined through use of the t-test and Chi-square statistic. Statistical significance was noted if a computed two-tailed probability value was less then 5% (P Ͻ 0.05). The SPSS PC+ computer program was used for statistical analysis.
Results
In order to determine if a relationship exists between the distinct genotypes for the I/D polymorphism of the ACE gene, the serum ACE activity, and the BP levels of persons, we conducted an epidemiological study in a population from the southeast of Spain. A total of 1322 randomised individuals were enrolled in the study. As a first approach a comparative study was carried out with 205 subjects from the highest BP group (fifth quintyl), and 196 from the lowest BP group (first quintyl) ( Table 1) . Allelic frequencies in this study were in Hardy-Weinberg equilibrium for the ACE I/D polymorphism.
The difference of allele frequencies and genotype distribution between the fifth quintyl group and the first quintyl group was not statistically significant for the entire population (P = 0.696) which included men and women (Table 2) .
We also studied the I/D polymorphism in men because previous works found a significant linkage of the ACE locus marker with diastolic BP in males. 16, 17 Nevertheless, in our population the difference of genotype frequencies between men with highest BP (fifth quintyl) and men with lowest BP (first quintyl) was not significant (P = 0.468) ( Table  2) , in agreement with a previous study. 18 We have not found a relationship between genotypes and family history of hypertension or evident clinical hypertension (data not shown). It has been reported that age could modulate the influence of ACE genetic variation on BP levels. In spite of that, we do not see a significant association between genotypes and BP in persons under 50 years of age (Table 2) .
For the ACE activity analysis, subjects who received antihypertensive drug treatment were eliminated. ACE activity was significantly higher in individuals with DD genotype than in individuals with ID genotype and with II genotype, for the fifth quintyl and first quintyl groups together (P Ͻ 0.0001) ( Table 3 ). There were not any differences in systolic and diastolic BP levels between genotype groups (Table 3) .
We could detect a modest linear relationship between ACE activity and systolic BP (r = 0.10; P Ͻ 0.05). A multivariate analysis was carried out to assess the independence between different factors. Among untreated participants ACE activity was not significantly related to systolic BP in a model which included BMI, age and gender. In a similar model but including ACE genotype, DD was not related with systolic BP levels ( Table 4) .
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Discussion
The influence of ACE gene polymorphisms on BP is under controversy. Despite evidence that the reninangiotensin system is an important determinant of blood pressure, and the complementary findings on the benefit of ACE inhibition, a direct relationship between the I/D ACE polymorphism and hypertension has been difficult to demonstrate. Various reports described the D allele as a risk factor for essential hypertension in various populations 6, 7 whereas other studies disagree with that hypothesis. [8] [9] [10] [11] [12] [13] Our work is, to our knowledge, the first one to be done in a Mediterranean population, and reveals no association between the I/D polymorphism and BP (Table 2 ). When we tested the serum activity of ACE in all of the individuals (fifth quintyl and first quintyl groups) it showed significantly higher values in individuals with more D alleles (DDϾDIϾII). Due to the fact that PCR amplification occurs in an intron, it can be suggested that such non-coding region would be implicated in the regulation of the ACE gene transcription, not excluding alternative explanations proposed by Tiret et al, 2 who say that two alternative hypotheses might explain how the variant identified here affects serum ACE levels. As a first hypothesis the low level of ACE would be an indirect consequence of a low expression of the ACE gene, a second hypothesis, the plasma level would be separately modified by a mutation that might either alter the proteolytic cleavage of ACE or decrease the expression of the mRNA for the soluble form.
Most reports demonstrate an association between a 287-bp deletion in the 16th intron of the ACE gene and an increment in ACE activity, but only a few of them associate the D allele with essential hypertension. ACE converts angiotensin I to angiotensin II, a potent vasopressor, and inactivates bradykidin, a vasodilator. That effect could explain the role of higher levels of ACE in determining BP. However, many other additional factors are also involved, such as substrate levels, interaction with angiotensin II receptors, presence of other peptidases, etc, all of them with their correspondent genetic determinants. The integration of all of them and the influence of environmental factors would determine the final effect of ACE gene variants on BP. This multifactorial determination could explain the contradictory results obtained in the analysis of I/D polymorphism by different authors.
Some authors have proposed a three-compartment model which seems appropriate to capture relationships between gene, ACE activity and BP levels. At the genetic level, a fixed effect, linked to the I/D polymorphism, determines a portion of the variance in serum ACE. At the level of the physiologic intermediate, ACE expression is further influenced by unmeasured environmental factors, and is correlated with body mass index (BMI) and BP. These two phenotypes are related to each other. 19 Due to this discrepancy the importance of using homologous populations in studies comparing ACE gene variants has been emphasised. Altogether these studies could contribute to create a map of the distribution of ACE allelic frequencies and the plausible influence of genetic and epigenetic factors on BP. For instance, one can speculate if the Mediterranean diet could play a role in disguising the genetic predisposition effect, if it exists, to have high BP.
